4/A: Centene CPO Amends Stock Holdings, Details Equity Awards

Centene's Chief People Officer, Tanya M. McNally, filed an amended Form 4 to adjust her beneficial ownership, reflecting new equity awards and unvested performance units.

Summary

• Tanya M. McNally, Chief People Officer of Centene Corp (CNC), filed an amended Form 4 (Form 4/A) on February 6, 2026.
• The amendment corrects her beneficial ownership reported in the original Form 4 filed on January 28, 2026.
• On January 26, 2026, McNally acquired 74,311 shares of Common Stock at a price of $0.
• This acquisition includes 29,724 restricted stock units (RSUs) that will vest in three annual installments beginning on March 15, 2027.
• The award also includes 44,587 performance stock units (PSUs) reported at target level performance, with actual vesting on March 15, 2029, ranging from 0% to 200% based on Centene's stock price performance.
• The amendment specifically removed 2,073 shares from the total holdings, representing unvested performance stock units for the performance period ending December 31, 2025, which did not meet vesting criteria as determined by the Compensation and Talent Committee on January 26, 2026.
• Following these reported transactions, McNally beneficially owns 131,007 shares, which includes 47,267 shares of previously-granted restricted stock units and performance stock units (reported at target level performance) subject to vesting requirements.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a largely neutral filing, primarily an administrative correction. While the non-vesting of some PSUs is a slight negative, the new equity award package for the Chief People Officer is a positive for executive alignment.

Positives

• Acquisition of 74,311 shares of Common Stock by a key executive, indicating continued alignment with company performance and long-term strategy.
• The new equity award structure includes both time-based (RSUs) and performance-based (PSUs) vesting, linking executive compensation directly to long-term company performance and stock price appreciation.

Negatives

• 2,073 performance stock units for the period ending December 31, 2025, did not meet their vesting criteria, indicating that certain performance targets were not achieved.

Risks

• The actual number of performance stock units that will vest on March 15, 2029, can range from 0% to 200% of the reported target, based on the Company's stock price performance, introducing variability in executive compensation outcomes.

Future Outlook

The vesting of 44,587 performance stock units on March 15, 2029, is contingent on Centene's stock price performance between the final 20 trading days of 2025 and the final 60 trading days of 2028, aligning executive incentives with future stock appreciation.

Industry Context

StockSavvy.ai notes that executive equity awards, particularly those with performance-based vesting, are a common practice in the healthcare managed care industry, aiming to align executive interests with long-term shareholder value. The adjustment for unvested PSUs highlights the rigorous application of performance criteria common across large-cap companies like UnitedHealth Group or Elevance Health, where compensation is increasingly tied to specific financial or operational metrics.

Comparison to Industry Standards

• The use of both Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) for executive compensation is a standard practice among S&P 500 companies, including peers like UnitedHealth Group (UNH) and Elevance Health (ELV), to balance retention and performance incentives.
• The specific vesting criteria for PSUs, tied to stock price performance over a multi-year period (2025-2028), is a common mechanism to incentivize long-term value creation, similar to programs seen at major healthcare providers.
• The non-vesting of 2,073 PSUs due to unmet criteria demonstrates the application of performance hurdles, a robust governance practice that ensures compensation is earned, aligning with best practices observed in companies like CVS Health (CVS) or Cigna (CI).

Corporate Governance

Stakeholder Impact

• Shareholders: The amendment provides clarity on executive beneficial ownership and the application of performance-based compensation, which can influence investor perception of governance and executive alignment. The non-vesting of some PSUs indicates that performance targets were not met, which could be viewed negatively.
• Employees: The Chief People Officer's compensation structure, including RSUs and PSUs, sets a precedent for executive incentives within the company.

Next Steps

• First annual vesting of 29,724 restricted stock units on March 15, 2027.
• Vesting of 44,587 performance stock units on March 15, 2029, contingent on stock price performance.

Key Dates

Recommendation

This filing is an administrative amendment to an insider transaction report, primarily clarifying executive equity holdings and the application of performance vesting criteria. While the non-vesting of a small portion of PSUs indicates unmet targets, it's not a material event that would significantly alter the investment thesis for Centene. The new equity awards align executive interests with long-term performance. Therefore, a 'hold' recommendation is appropriate as this filing does not present new information warranting a change in investment strategy.

Keywords

Centene Corp, CNC, Form 4/A, Beneficial Ownership, Executive Compensation, Restricted Stock Units, Performance Stock Units, Insider Transaction, SEC Filing